Planned Parenthood Using Gender Services to Target Teen Girls
To read other articles from this issue of WSR: Click here

On February 8, 2021, Abigail Shrier released an article in her newsletter “The Truth Fairy,” which was picked up and reprinted by The Federalist. As The Federalist noted, Abigail Shrier is a frequent contributor to the Wall Street Journal and the author of Irreversible Damage: The Transgender Craze Seducing Our Daughters. She earned an AB from Columbia College, where she received the Euretta J. Kellett Fellowship; a BPhil from the University of Oxford; and a JD from Yale Law School.

Shrier’s article, entitled “Inside Planned Parenthood’s Gender Factory,” was centered on a former Planned Parenthood employee who had no problem with Planned Parenthood’s abortion business but who left because she witnessed Planned Parenthood giving “cross-sex hormones like testosterone to females seeking medical gender transition” in an unethical manner. She actually described Planned Parenthood’s role in trans activism as being “abhorrent.” She said: “They’re digging their own grave.”

According to Shrier, “The employee’s responsibilities included screening patients, taking down their lists of medications and medical histories before the nurse arrived to treat.”  

Shrier continued: “There were no doctors at the clinic where she worked. Nurse practitioners were the professionals with the highest medical training, she said. The clinic employed a gender counselor who had ‘no actual professional credentials or formal training other than being MtF’ (that is, a male-to-female transgender person). Adolescents would come and speak to this gender counselor and Planned Parenthood would then forward the counselor’s ‘notes to an actual licensed mental health professional somewhere off-site, and rubber stamp approve the patients to begin their transition.'”

Shrier continued: “Whether patients received specific treatments—a course of testosterone, say—was decided by the ‘clinic manager,’ with ‘no prior medical experience’ whose prior job was ‘managing a Wendy’s.’ . . . Each day, new teen girls would present at the clinic (sometimes with mom). They often arrived in groups of girlfriends, all claiming childhood histories of gender dysphoria and asking to be put on testosterone.”

Shrier then wrote: “In taking their histories, the employee did discover that these girls seemed to be suffering from a great deal of emotional pain. ‘A lot of them have serious emotional issues, a lot of them had a history of abuse and baggage.’”

According to Shrier, “Anxiety, depression, and bipolar disorder were ubiquitous. Often, the employee said, they had visible ‘self-harm scars’ and even ‘fresh self-harm marks.’ But, she said, the medical professionals were never supposed to address those marks. ‘We just move on exactly the issue at hand’—that is, affirming the adolescents’ self-diagnosed dysphoria and proceeding to a course of treatment.”

Shrier explained that “this treatment—testosterone—carries serious risks for adolescent girls, particularly at the doses at which it is administered, ten to forty times what their bodies would normally handle. Risks include deepened voice, enlarged clitoris, increase in red blood cell count and greater risk of heart attack, infertility, vaginal and uterine atrophy, endometrial cancer—as well as all the unknown risks [that] come with any major and novel intervention.”

The employee “would present the girls with pages that listed a series of medical risks and obtain signatures indicating their ‘informed consent.’” Shrier asked: “Did any of the girls ever seem troubled by these risks?” The employee responded: “I can say anecdotally that I never saw anybody read it.”

Shrier found the fact troubling that, according to the employee, the girls would often arrive at the clinic with a group of friends. She asked the employee “if she and the other nurses and reproductive health assistants didn’t think there was something suspicious about girls’ showing up in groups of friends for treatment—whether it didn’t cross the employees’ minds that peer influence might be at play.” The employee told Shrier: “It’s kind of one of those things where you just roll your eyes.” According to the employee, “‘The extent of our intervention’ was to grant ‘their requests to start the hormone therapy.'”

Shrier asked if the employee or other staff members voiced “their misgivings about whether they were giving these girls the best treatment.” The employee responded: “Yeah. Every day. . . . I mean, it would be one of those things that would be a conversation among professionals. You know, we’re nodding our heads, we’re doing this thing. And then we clock out at the end of the day because we cannot bring it up in discussion with management or the clinic directors or anything because they have these directives from administrators upstate.”

Shrier also asked the employee if, “as far as she knew, any of the girls asking to start a course of testosterone ever get turned down. [Or if] perhaps some were sent for psychiatric evaluation before proceeding with testosterone treatment? ‘None of the girls,’ the employee said.”

STOPP’s comment:

These are the transgender services Planned Parenthood brags about to anyone who will listen. Since those people who change genders must take the hormones for the rest of their lives, it is a big dollar item for Planned Parenthood, and current evidence is that this fact is what has Planned Parenthood so interested.

Next, we will trace Planned Parenthood’s involvement in this sordid business.